학술논문
A Phase 3 Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of AB-205 Plus Standard of Care (SOC) Versus Placebo Plus Standard of Care in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (E-CELERATE) (NCT05181540) - Trials in Progress
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:10573-10574
Subject
Language
ISSN
0006-4971